{
|
"batch_id": "BATCH-STOCK-VALUATION-20260805-004",
|
"ticker": "688192.SH",
|
"company": "迪哲医药",
|
"information_cutoff": "2026-08-04T23:40:00+08:00",
|
"market_date": "2026-08-04",
|
"v2_status": "BLOCKED",
|
"v2_failure_package": "ai-valuation-analyst/tmp/valuation_batch_20260805_004/v2_688192_SH.failed-268580f53b214f439967d24d69c5deb1",
|
"v2_failure_reason": "ValueError: E_HISTORICAL_SHARES_UNPROVEN：quote f124 缺失或为 0",
|
"raw_hashes": [
|
"d97bc6583019a59b50ae4ec8e6f0aff1651f080a185884b018c2e18061b5dc59",
|
"d7a74a919ee32927ce7529c1c17b73b7ac423f5789d8d831e3b793d46a12682e",
|
"fdfa515e400f7cf73e957e6ca3f2d2ce90ab17b25038f2b384ddef8838293713",
|
"447240c413fac2ee60f67e9c3963b53f366185090556b7339bf2ec5ed871888a",
|
"ddcf12afbf1e9203646a8f15fa90195f6ff1a6edc81b551991a37841b364699e",
|
"3e81ac75568e3ab053e11500b931af918a1057b8925fc6a223743799fd358cd4",
|
"bca816fe9fcf816de6e3282d42768d36c0be51f7e9cf42363f7165be213f7e35",
|
"8c222be2f957d2445377dd812d41faa1e765642833479fbdd8e3c425d453569b",
|
"28d488096c1d50f8c0b2a6dd2c50f6e883d61fa865dd8b788ed19f4736cb3d9d",
|
"bdb687797a171f68c92ea6f0b8d6592fd5e651d25c2d22c1e4c2b761343fe959"
|
],
|
"market_evidence": {
|
"source": "trading_xuntou.cn_stock_kline_1d_front:xtquant:front",
|
"quote_raw_hashes": [
|
"28d488096c1d50f8c0b2a6dd2c50f6e883d61fa865dd8b788ed19f4736cb3d9d",
|
"bdb687797a171f68c92ea6f0b8d6592fd5e651d25c2d22c1e4c2b761343fe959"
|
],
|
"platform_market_cap_excluded": 24667744601.260002
|
},
|
"share_proof_status": "QUOTE_EXACT_A1_NEAR_MATCH",
|
"share_proof": {
|
"report_shares": 464633342.0
|
},
|
"manual_finance_override": {
|
"used": false,
|
"reason": null
|
},
|
"checks": {
|
"price_times_shares": 23379235218.92,
|
"platform_market_cap": 23379235218.92,
|
"market_cap_gap_rate": 0.0
|
},
|
"bounded_gaps": [
|
"quote f124=0，V2没有伪造历史股本日期；正式报告按A1股份变动公告或估值日数量校验人工补证。",
|
"机构汇总缺逐家日期与明细。",
|
"当前行情股本与最近A1股本存在小额持续变化，精确日期未由f124证明。"
|
]
|
}
|
